Nls pharmaceuticals to reschedule company update on strategic discussions

Zurich, switzerland / accesswire / october 19, 2023 / nls pharmaceutics ltd. (nasdaq:nlsp, nlspw) ("nls" or the "company"), a swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced that it will postpone the company update previously scheduled for friday, october 20, 2023, due to important developments impacting the timing of the event.
NLSP Ratings Summary
NLSP Quant Ranking